Your Advocates Ltd’s Aurinia Pharmaceuticals AUPH Stock Holding History

Your Advocates Ltd’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.39K	Hold	200	–	–	﹤0.01%	162
2026 Q1	$2.96K	Hold	200	–	–	﹤0.01%	166
2025 Q4	$3.19K	Hold	200	–	–	﹤0.01%	169
2025 Q3	$2.21K	Hold	200	–	–	﹤0.01%	166
2025 Q2	$1.69K	Hold	200	–	–	﹤0.01%	162
2025 Q1	$1.61K	Hold	200	–	–	﹤0.01%	167
2024 Q4	$1.8K	Hold	200	–	–	﹤0.01%	166
2024 Q3	$1.47K	Hold	200	–	–	﹤0.01%	184
2024 Q2	$1.14K	Hold	200	–	–	﹤0.01%	195
2024 Q1	$1K	Hold	200	–	–	﹤0.01%	192
2023 Q4	$1.8K	Hold	200	–	–	﹤0.01%	176
2023 Q3	$1.55K	Hold	200	–	–	﹤0.01%	216
2023 Q2	$1.94K	Hold	200	–	–	﹤0.01%	213
2023 Q1	$2.19K	Hold	200	–	–	﹤0.01%	171
2022 Q4	$864	Hold	200	–	–	﹤0.01%	186
2022 Q3	$2K	Hold	200	–	–	﹤0.01%	143
2022 Q2	$2K	Sell	200 -1,500	-88%	-$16.8K	﹤0.01%	151
2022 Q1	$21K	Buy	1,700 +1,550	+1,033%	+$24K	0.01%	73
2021 Q4	$3K	Sell	150 -100	-40%	-$2.37K	﹤0.01%	140
2021 Q3	$6K	Buy	+250	New	+$3.97K	﹤0.01%	110

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Your Advocates Ltd's AUPH Position: Q2 2026 in Review

Your Advocates Ltd held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 200 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #162.

Your Advocates Ltd first reported a position in AUPH in Q3 2021 and has held it in 20 quarters since. The position peaked at $21K in Q1 2022. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Your Advocates Ltd held 200 shares of Aurinia Pharmaceuticals worth $3.39K as of Q2 2026.
Your Advocates Ltd left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Your Advocates Ltd's portfolio in Q2 2026, its #162 holding.
Your Advocates Ltd first reported a position in Aurinia Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
Your Advocates Ltd's Aurinia Pharmaceuticals position peaked at $21K in Q1 2022.
282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Your Advocates Ltd's 13F filing for Q2 2026, filed 5 Aug 2026.